SCHEMBL1896833

SCHEMBL1896833

OC(CNC(c1cccc(Oc2ccnc(C(F)(F)F)c2)c1)c1cccc(C(F)(F)C(F)(F)F)c1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CETP P11597 7/20 0.36
PNMT P11086 1/20 0.35
SCN9A Q15858 1/20 0.35
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5671333 1.00 CETP (0.36) CETPPNMTSCN9AKDR
SCHEMBL1565209 0.94 CETP (0.35) CETPPNMTSCN9AKDR
SCHEMBL6569703 0.94 CETP (0.35) CETPPNMTSCN9AKDR
SCHEMBL6568915 0.88 CETP (0.41) CETP
SCHEMBL5670346 0.88 CETP (0.41) CETP
SCHEMBL5668806 0.87 CETP (0.41) CETPPNMT
SCHEMBL6270876 0.86 CETP (0.37) CETP
SCHEMBL1563718 0.86 CETP (0.37) CETP
SCHEMBL992083 0.86 CETP (0.43) CETP
SCHEMBL6280371 0.86 CETP (0.43) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP claimed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO claimed
EP-2316447-A1 Method of inhibiting remnant lipoprotein production Japan Tobacco, Inc. (JP) 2011-05-04 EP disclosed
WO-2005117869-A1 COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-12-15 WO disclosed
EP-1469831-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS Pfizer Products Inc. (US) 2004-10-27 EP disclosed
WO-2003063832-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLID AMORPHOUS DISPERSION OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS PFIZER PRODUCTS INC. (US) 2003-08-07 WO disclosed